More on SRZN

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+87.3% Growth)
- Ratings (7.5 Score)

Upcoming Events

- Earnings (11/11/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Surrozen (NQ:SRZN)
Delayed: 23.44 -1.63 (6.5%)
Prev. Close $25.07  
Open$25.09 
52 Wk High$ 
52 Wk Low$ 
Day High$25.09 
Day Low$23.25 
P/E N/A  
EPS$ 
Volume269,022 


Oct 15, 2026 01:57 PM Top Biotech Stock: Guggenheim Names Surrozen as Best Pick
Oct 7, 2026 07:07 PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: Boxer Capital Management, LLC
Oct 2, 2026 08:06 AM Form 8-K Surrozen, Inc./DE For: Oct 02
Oct 2, 2026 08:02 AM Surrozen gets FDA IND clearance for DME drug, expects $95.1M funding
Oct 2, 2026 08:00 AM Surrozen Announces FDA Clearance of IND Application for SZN-8141 for the Treatment of Diabetic Macular Edema
Oct 1, 2026 05:00 PM Form SCHEDULE 13G Surrozen, Inc./DE Filed by: Commodore Capital LP
Sep 25, 2026 06:48 AM Surrozen Inc. (SRZN) PT Raised to $54 at H.C. Wainwright
Aug 20, 2026 05:57 AM William Blair Starts Surrozen Inc. (SRZN) at Outperform
Aug 14, 2026 04:16 PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: BRAIDWELL LP
Aug 14, 2026 04:09 PM Form SCHEDULE 13G/A Surrozen, Inc./DE Filed by: Boxer Capital Management, LLC
View All Articles

Entities mentioned with SRZN

View All Entities